Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001999371-24-012209
Filing Date
2024-09-20
Accepted
2024-09-20 17:03:56
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT FOR SPECIFIED TRANSACTIONS tonix_s3-092024.htm S-3 248573
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 21960
3 OPINION OF LOWENSTEIN SANDLER, LLP ex5-02.htm EX-5.02 19172
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-01.htm EX-23.01 2983
5 CALCULATION OF FILING FEE TABLES ex-107.htm EX-FILING FEES 36316
6 GRAPHIC ls_logo.jpg GRAPHIC 18186
7 GRAPHIC tonixs3001.jpg GRAPHIC 19763
8 GRAPHIC brownstein_logo.jpg GRAPHIC 15938
  Complete submission text file 0001999371-24-012209.txt   404753
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282270 | Film No.: 241314049
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)